ERAS Erasca, Inc.
Healthcare · Market cap: $5.5B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $426.2K | $0 |
| 2023-Q1 | $515.6K | $0 |
| 2023-Q2 | $330.2K | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $3.8M | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $181.6K | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $971.6K |
| 2026-Q2 | $0 | $1.3M |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$5.3M14 buy days
Sold$2.3M3 sell days
Net insider flow+$3.0Mnet buying · 5 years
Latest trade2026-04-01Garner Ebun
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-04-01 | Sell | Garner Ebun | Other C-suite | 80,000 | $16.40 | $1.3M | 1 |
| 2026-03-04 | Sell | Morris Shannon | Other C-suite | 20,000 | $15.04 | $300.8K | 1 |
| 2026-01-07 | Sell | Garner Ebun | General counsel | 120,000 | $5.59 | $670.8K | 1 |
| 2024-05-21 | Buy | Casdin Alexander W. | Director | 80,000 | $2.27 | $181.6K | 1 |
| 2023-12-06 | Buy | Lim Jonathan E | CEO | 278,150 | $1.72 | $478.4K | 1 |
| 2023-12-06 | Buy | Start Valerie Denise Harding | Director | 10,000 | $1.85 | $18.5K | 1 |
| 2023-12-05 | Buy | Lim Jonathan E | CEO | 721,850 | $1.69 | $1.2M | 1 |
| 2023-12-04 | Buy | Casdin Alexander W. | Director | 30,000 | $1.66 | $49.8K | 1 |
| 2023-10-05 | Buy | Lim Jonathan E | CEO | 1,000,000 | $2.03 | $2.0M | 1 |
| 2023-06-08 | Buy | Lim Jonathan E | CEO | 100,000 | $2.75 | $275.0K | 1 |
| 2023-04-10 | Buy | Casdin Alexander W. | Director | 20,000 | $2.76 | $55.2K | 1 |
| 2023-03-28 | Buy | Lim Jonathan E | CEO | 100,000 | $2.84 | $284.0K | 1 |
| 2023-01-10 | Buy | Lim Jonathan E | CEO | 60,000 | $3.86 | $231.6K | 1 |
| 2022-12-21 | Buy | Bristol James Arthur | Director | 20,000 | $4.14 | $82.8K | 1 |
| 2022-12-21 | Buy | Start Valerie Denise Harding | Director | 10,000 | $4.64 | $46.4K | 1 |
| 2022-12-15 | Buy | Casdin Alexander W. | Director | 20,000 | $4.87 | $97.4K | 1 |
| 2022-12-14 | Buy | Lim Jonathan E | CEO | 40,000 | $4.99 | $199.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Lim Jonathan E | CEO | $4.7M | $0 | 2023-12-06 |
| Garner Ebun | Other C-suite | $0 | $2.0M | 2026-04-01 |
| Casdin Alexander W. | Director | $384.0K | $0 | 2024-05-21 |
| Morris Shannon | Other C-suite | $0 | $300.8K | 2026-03-04 |
| Bristol James Arthur | Director | $82.8K | $0 | 2022-12-21 |
| Start Valerie Denise Harding | Director | $64.9K | $0 | 2023-12-06 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-12-04 → 2023-12-06 | 3 | $1.8M | 62 | +4.3% (+10.0% raw) | +1.6% (+12.6% raw) | +9.1% (+18.4% raw) | closed |
| 2022-12-14 → 2023-01-10 | 4 | $657.8K | 59 | -18.6% (-9.9% raw) | -37.2% (-36.9% raw) | -44.9% (-38.0% raw) | closed |
| 2021-07-20 → 2021-08-10 | 5 | $19.9M | 38 | +1.0% (+2.8% raw) | -13.2% (-8.6% raw) | -47.4% (-42.2% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.